comparemela.com
Home
Live Updates
Sarilumab Demonstrates Sustained Remission in Patients with
Sarilumab Demonstrates Sustained Remission in Patients with
Sarilumab Demonstrates Sustained Remission in Patients with Polymyalgia Rheumatica
At week 52, sustained remission was observed in significantly more patients receiving sarilumab compared with placebo.
Related Keywords
Polymyalgia Rheumatica ,
Robertf Spiera ,
Myositis Center At Hospital For Special Surgery ,
Clinical Medicine At Weill Cornell Medical College ,
New England Journal ,
Myositis Center ,
Special Surgery ,
Clinical Medicine ,
Weill Cornell Medical College ,
Autoimmune ,
Autoimmune Disorder ,
Stem Cell Therapy ,